NewTPO treatment schedules of increased safety and efficacy:pre-clinical validation of a thrombopoiesis simulation model

MLA

Skomorovski, K., et al. NewTPO Treatment Schedules of Increased Safety and Efficacy:Pre-Clinical Validation of a Thrombopoiesis Simulation Model. Jan. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........8cd1bc62c95590cd86af595f953a43e9&authtype=sso&custid=ns315887.

APA

Skomorovski, K., Harpak, H., Ianovski, A., Vardi, M., Visser, T., Hartong, S., van Vliet, H., Wagemaker, G., & Agur, Z. (2003). NewTPO treatment schedules of increased safety and efficacy:pre-clinical validation of a thrombopoiesis simulation model.

Chicago

Skomorovski, K, H Harpak, A Ianovski, M Vardi, Trui Visser, Scc Hartong, Hhdm van Vliet, Gerard Wagemaker, and Z Agur. 2003. “NewTPO Treatment Schedules of Increased Safety and Efficacy:Pre-Clinical Validation of a Thrombopoiesis Simulation Model,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........8cd1bc62c95590cd86af595f953a43e9&authtype=sso&custid=ns315887.